Saturday, December 3, 2022

ScreenPoint Medical Announces its New International Medical Advisory Board

ScreenPoint Medical, the company that developed the world leading Transpara® AI breast care system, today announced the launch of its new Medical Advisory Board (MAB) comprised of distinguished leaders in breast radiology from both sides of the Atlantic.

The MAB will help the company better understand the external medical and imaging environment, in particular the junction between imaging, breast AI, and cancer detection.  Additionally, we look forward to guidance on both existing products, those under development and future unmet market needs. Transpara Breast AI, which is now in daily use across the United States and in more than 30 other countries worldwide, has received endorsement from more peer reviewed scientific papers than any other breast AI product.

The new MAB brings together a unique team of renowned experts in the field who will have a continuing influence on the development of Transpara internationally.

“We are thrilled that such respected professionals have decided to join our Medical Advisory Board, “said Mark Koeniguer, CEO of ScreenPoint Medical. “Together, they bring an unparalleled wealth of experience to help guide us to the next level of development, and to ensure we can bring high impact solutions to clinicians while benefiting patients in our joint fight against breast cancer.”

The members of the new ScreenPoint Medical Advisory Board are:

  • Dr. Jennifer Harvey is Professor and Chair at the University of Rochester Department of Imaging Sciences. Harvey is an international expert in breast imaging and the early detection of breast cancer. Previously, she was on faculty at the University of Virginia for 26 years, leading its Division of Breast Imaging, Breast Cancer Program, and serving as vice-chair for Education and Faculty Development. Dr. Harvey’s primary research interest is mammographic breast density and the association with breast cancer risk.
  • Laurie Margolies, Md, Director Of Breast Imaging At Mount Sinai Health System
    Laurie Margolies, Md, Director Of Breast Imaging At Mount Sinai Health System

    Laurie Margolies, MD, Director of Breast Imaging at Mount Sinai Health System, an American College of Radiology fellow and past-President of the New York Breast Imaging Society.  Dr. Margolies received her medical degree from Yale School of Medicine and has been in practice for more than 20 years.  Her research interests include health care disparities, breast MRI, breast density and digital breast tomosynthesis. Dr. Margolies is an uncompensated consultant for ScreenPoint Medical.

  • Dr Ritse Mann, Breast And Interventional Radiologist At The Radboud University Medical Center
    Dr Ritse Mann, Breast And Interventional Radiologist At The Radboud University Medical Center

    Dr. Ritse Mann is a breast and interventional radiologist at the Radboud University Medical Center in Nijmegen and the Netherlands Cancer Institute in Amsterdam and is leading clinical breast imaging research at both institutions. His areas of interest include breast cancer screening, breast MRI, minimal invasive therapy and the use of artificial intelligence for screening, diagnosis and therapy selection of breast cancer. Dr. Mann is a member of the executive board of the European society of breast imaging (EUSOBI) since 2015 and  chairing its scientific committee and the  program planning committee of the annual meeting.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Bone Health Technologies announces positive Topline Results from Groundbreaking Pivotal Trial of Non-pharmacological Treatment for Osteopenia

The trial by Bone Health Technologies was conducted in partnership with Laura Bilek, Ph.D., the Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC) and expert in clinical research for the treatment of low bone mass.

Covalon’s SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children’s Hospital

Jeremy Harman, PA-C, an author of the study, commented, "The trifecta of breathable barrier protection, antimicrobials, and the ability to monitor the site is what makes this a great dressing. It's easier for us to assess the wound and is more comfortable for patients."

Verve Medical Announces Results of Feasibility Trial for Transurethral Renal Pelvic Denervation for Uncontrolled Hypertension

The results of the Verve study were published last week in the American Heart Association’s (“AHA”) Hypertension journal. Hypertension is the leading risk factor for preventable deaths worldwide. See link to AHA publication below: (

By using this website you agree to accept Medical Device News Magazine Privacy Policy